R Squared’s Merck MRK Stock Holding History

R Squared’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,150	Closed	-$373K	–	535
2025 Q1	$373K	Buy	+4,150	New	+$387K	0.4%	90

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

R Squared's MRK Position: Q2 2025 in Review

R Squared sold out of Merck (MRK) in Q2 2025, closing a stake of 4,150 shares — an estimated $373K sold.

R Squared first reported a position in MRK in Q1 2025 and held it in 1 quarter. The position peaked at $373K in Q1 2025. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

R Squared reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
R Squared sold 4,150 Merck shares in Q2 2025, an estimated $373K.
R Squared first reported a position in Merck in Q1 2025 and held it in 1 quarter.
R Squared's Merck position peaked at $373K in Q1 2025.
3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on R Squared's 13F filing for Q2 2025, filed 31 Jul 2025.